FDA Import Refusal 8NP-0056005-6/11/1 — Abbvie Biotechnology Gmbh
The FDA refused shipment 8NP-0056005-6/11/1 from Abbvie Biotechnology Gmbh (Germany) on Feb 9, 2021. The refused product falls under Drugs and Biologics — ADALIMUMAB. Cited charges: 118,2280,3280,71,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 9, 2021
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 61YCL02 ADALIMUMAB
- Charges
- 118,2280,3280,71,75